Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• LeboulleuxSRubinoCBaudinEPrognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosisJ Clin Endocrinol Metab200590105723572916030160
   PubMed Web of Science ®Google Scholar
• MorrisLGTuttleRMDaviesLChanging trends in the incidence of thyroid cancer in the United StatesJAMA Otolaryngol Head Neck Surg2016142770971127078686
   PubMed Web of Science ®Google Scholar
• BurnsWRZeigerMADifferentiated thyroid cancerSemin Oncol201037655756621167375
   PubMed Web of Science ®Google Scholar
• ItoYMiyauchiAPrognostic factors and therapeutic strategies for differentiated carcinomas of the thyroidEndocr J200956217719218703852
   PubMed Web of Science ®Google Scholar
• KimSKKwonAYBackKPredictive factors of lymph node metastasis in follicular variant of papillary thyroid carcinomaAnn Surg Oncol20172492617262328685355
   PubMed Web of Science ®Google Scholar
• LundgrenCIHallPDickmanPWZedeniusJClinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case–control studyCancer2006106352453116369995
   PubMed Web of Science ®Google Scholar
• ZidanJKarenDSteinMPure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survivalCancer20039751181118512599223
   PubMed Web of Science ®Google Scholar
• MustafaMKuwertTWeberKRegional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT studyEur J Nucl Med Mol Imaging20103781462146620358197
   PubMed Web of Science ®Google Scholar
• SchneiderDFChenHNew developments in the diagnosis and treatment of thyroid cancerCA Cancer J Clin2013636373394
   Web of Science ®Google Scholar
• LeeYCNaSYParkGCOccult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: a multi-institutional studySurgery2017161246547127574773
   PubMed Web of Science ®Google Scholar
• LeeYMSungTYKimWBRisk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissectionBr J Surg201610381020102527121346
   PubMed Web of Science ®Google Scholar
• LiuFHKuoSFHsuehCChaoTCLinJDPostoperative recurrence of papillary thyroid carcinoma with lymph node metastasisJ Surg Oncol2015112214915426175314
   PubMed Web of Science ®Google Scholar
• XingMBRAF mutation in thyroid cancerEndocr Relat Cancer200512224526215947100
   PubMed Web of Science ®Google Scholar
• XingMLiuRLiuXBRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrenceJ Clin Oncol201432252718272625024077
   PubMed Web of Science ®Google Scholar
• HouPLiuDShanYLiuZGenetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancerClin Cancer Res20071341161117017317825
   PubMed Web of Science ®Google Scholar
• BackersKBleroDPaternotteNZhangJErneuxCThe termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatasesAdv Enzyme Regul200343152812791379
   PubMedGoogle Scholar
• RaaijmakersJHDeneubourgLRehmannHThe PI3K effector Arap3 interacts with the PI(3,4,5)P3 phosphatase SHIP2 in a SAM domain-dependent mannerCell Signal20071961249125717314030
   PubMed Web of Science ®Google Scholar
• Elong EdimoWSchurmansSRogerPPErneuxCSHIP2 signaling in normal and pathological situations: its impact on cell proliferationAdv Biol Regul20145414215124091101
   PubMedGoogle Scholar
• Elong EdimoWGhoshSDeruaRSHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cellsJ Cell Sci201612961101111426826186
   PubMed Web of Science ®Google Scholar
• YeYGeYMXiaoMMSuppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of AktJ Gastroenterol201651323024026201869
   PubMed Web of Science ®Google Scholar
• PrasadNKTandonMBadveSSnyderPWNakshatriHPhospho-inositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnoverCarcinogenesis2008291253417893231
   PubMed Web of Science ®Google Scholar
• FuMFanWPuXElevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancerInt J Clin Exp Pathol20136102185219124133597
   PubMed Web of Science ®Google Scholar
• FuMGuXNiHHigh expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinomaInt J Clin Exp Pathol20136112515252224228114
   PubMed Web of Science ®Google Scholar
• PrasadNKTandonMHandaAHigh expression of obesity-linked phosphatase SHIP2 in invasive breast cancer correlates with reduced disease-free survivalTumour Biol200829533034119065064
   PubMedGoogle Scholar
• YangJFuMDingYHigh SHIP2 expression indicates poor survival in colorectal cancerDis Markers20142014218968725525286
   PubMed Web of Science ®Google Scholar
• WangQXChenEDCaiYFA panel of four genes accurately differentiates benign from malignant thyroid nodulesJ Exp Clin Cancer Res201635116927793213
   PubMed Web of Science ®Google Scholar
• SuwaAKuramaTShimokawaTSHIP2 and its involvement in various diseasesExpert Opin Ther Targets201014772773720536411
   PubMed Web of Science ®Google Scholar
• PrasadNKSHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cellsInt J Oncol20093419710519082482
   PubMed Web of Science ®Google Scholar
• FuCHLinRJYuJA novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activationStem Cells20143282048206024802135
   PubMed Web of Science ®Google Scholar
• HoekstraEdasAMWillemsenMLipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activationOncotarget2016745735257354027716613
   PubMedGoogle Scholar